• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[前列腺腺癌的发病及生存情况。对连续48例患者进行10年研究的分析]

[Onset of and survival in adenocarcinoma of the prostate. Analysis of 48 consecutive cases studied over 10 years].

作者信息

Goodman C M, Chisholm G D

出版信息

Arch Esp Urol. 1989;42 Suppl 2:117-23.

PMID:2700880
Abstract

Four hundred and thirty-eight men with histologically confirmed prostatic adenocarcinoma were diagnosed consecutively and followed up closely for up to ten years. The mean age at presentation was 72.5 years and ranged from 45.3 to 91.0 years. Half of the total presented with symptoms of increasing urinary outflow obstruction and a quarter with acute urinary retention. One fifth of the total were diagnosed incidentally and these men had markedly less risk of progressing to skeletal metastases than those with localised, but clinically detectable disease. Most (60%) had locally advanced or metastatic disease at the time of diagnosis and the prevalence of skeletal metastases was seen to increase with local tumour stage. 40% had skeletal metastases at diagnosis and less than half of these patients survive two years. High grade tumours were associated with poor outcome, with a five year survival of less than 20% when the Gleason sum score was greater than seven.

摘要

438名经组织学确诊为前列腺腺癌的男性患者被连续诊断,并进行了长达十年的密切随访。就诊时的平均年龄为72.5岁,范围在45.3岁至91.0岁之间。总患者中有一半出现排尿流出梗阻加重的症状,四分之一出现急性尿潴留。总患者中有五分之一是偶然诊断出来的,这些男性进展为骨转移的风险明显低于那些有局限性但临床可检测到疾病的患者。大多数(60%)在诊断时患有局部晚期或转移性疾病,骨转移的患病率随着局部肿瘤分期的增加而增加。40%的患者在诊断时有骨转移,这些患者中不到一半能存活两年。高级别肿瘤与不良预后相关,当Gleason总分大于7分时,五年生存率低于20%。

相似文献

1
[Onset of and survival in adenocarcinoma of the prostate. Analysis of 48 consecutive cases studied over 10 years].[前列腺腺癌的发病及生存情况。对连续48例患者进行10年研究的分析]
Arch Esp Urol. 1989;42 Suppl 2:117-23.
2
Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.冰岛前列腺腺癌:一项基于人群的研究,涉及1983年至1987年间确诊的男性患者的分期、Gleason分级、治疗及长期生存情况。
Scand J Urol Nephrol. 2006;40(4):265-71. doi: 10.1080/00365590600750110.
3
[Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].[前列腺腺癌在诊断时发生转移的演变及预后因素]
Actas Urol Esp. 1997 Sep;21(8):724-36.
4
[Epidemiologic indicators of adenocarcinoma of the prostate. Results on 436 patients].[前列腺腺癌的流行病学指标。436例患者的结果]
Actas Urol Esp. 1997 Oct;21(9):852-61.
5
[Clinical study of prostate cancer--statistical analysis in the last 10 years].
Hinyokika Kiyo. 1991 Jul;37(7):705-10.
6
Prostate carcinoma--the value of T stage and grade in predicting metastases and prognosis. A cost-effective approach to clinical staging.前列腺癌——T分期和分级在预测转移及预后方面的价值。一种临床分期的性价比高的方法。
S Afr J Surg. 1991 Mar;29(1):15-8.
7
Results of the primary treatment in T1-3M0 prostatic adenocarcinoma are dependent on tumour biology.T1-3M0期前列腺腺癌的初始治疗结果取决于肿瘤生物学特性。
Anticancer Res. 1995 Mar-Apr;15(2):569-73.
8
Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.雄激素受体在前列腺癌淋巴结转移中的表达可预测手术后的预后。
J Urol. 1999 Apr;161(4):1233-7.
9
A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy.Gleason评分为7预示着接受放射治疗的前列腺癌患者预后较差。
Cancer. 1998 Sep 1;83(5):971-6.
10
Prostatic cancer in patients 80 years of age.80岁患者的前列腺癌。
Prog Clin Biol Res. 1987;243B:321-7.